RT @Dra_TeraizaMesa:
RT @Dra_TeraizaMesa: RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu…
RT @Dra_TeraizaMesa: RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu…
RT @Dra_TeraizaMesa: RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu…
RT @Dra_TeraizaMesa: RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu…
RT @Dra_TeraizaMesa: RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu…
RT @Dra_TeraizaMesa: RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu…
RT @Dra_TeraizaMesa: RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu…
RT @Dra_TeraizaMesa: RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu…
RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/AaRNu9k9DC
RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/tw7WPlRPLa
RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/tw7WPlRPLa
RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/tw7WPlRPLa
RT @_atanas_: Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/tw7WPlRPLa
Burden of unique and low prevalence somatic mutations correlates with cancer survival https://t.co/tw7WPlRPLa
New from #OfficialNIHR https://t.co/foDWQnvDG6 Burden of unique and low prevalence somatic mutations correlates with cancer survival
RT @ingentium_mel: Burden of unique and low prevalence somatic mutations correlates with cancer survival. https://t.co/XYXVAz4MCu
Burden of unique and low prevalence somatic mutations correlates with cancer survival. https://t.co/XYXVAz4MCu
Burden of unique and low prevalence somatic mutations correlates with cancer survival. #amchelsinki #tutkimus https://t.co/JI3hNv3aI5
RT @niklebanov: My new work discussing how mutational burden affects cancer survival, and how passenger mutations may be playing a role. Sp…
My new work discussing how mutational burden affects cancer survival, and how passenger mutations may be playing a role. Special thanks to MA and HT for their contributions and support. https://t.co/PqZWXzf7f5